The options between Roche and Genentech get even more interesting. With big companies taking over today and economic decisions being made, you can't really blame them. Also, good scientists are worth their weight in gold, so there's always the potential of discussions with venture capital folks for new start ups as a potential threat as well. What is really nice here is that the bonuses go through whether or not the buy out is successful or not. BD
Genentech said Thursday that it would spend up to $371 million on retention bonuses to keep its employees from leaving because of the possible acquisition of the company by its majority shareowner, Roche.
0 comments :
Post a Comment